Published in J Clin Psychiatry on January 01, 2004
The psychopharmacology of agitation: consensus statement of the american association for emergency psychiatry project Beta psychopharmacology workgroup. West J Emerg Med (2012) 1.29
Antipsychotic-induced extrapyramidal side effects in bipolar disorder and schizophrenia: a systematic review. J Clin Psychopharmacol (2008) 1.19
The impact of comparative effectiveness research on health and health care spending. J Health Econ (2011) 0.98
Comparative effectiveness research for antipsychotic medications: how much is enough? Health Aff (Millwood) (2009) 0.97
Pharmacogenetics of antipsychotic-induced side effects. Dialogues Clin Neurosci (2009) 0.92
Remission of irreversible aripiprazole-induced tardive dystonia with clozapine: a case report. BMC Psychiatry (2015) 0.85
Pharmacogenetics in mood disorder. Curr Opin Psychiatry (2005) 0.84
Low-Dose Risperidone-Induced Oculogyric Crises in an Adolescent Male with Autism, Tourette's and Developmental Delay. J Can Acad Child Adolesc Psychiatry (2011) 0.81
Prevalence of movement disorders in adolescent patients with schizophrenia and in relationship to predominantly atypical antipsychotic treatment. Eur Child Adolesc Psychiatry (2006) 0.80
Number needed to treat and number needed to harm with paliperidone palmitate relative to long-acting haloperidol, bromperidol, and fluphenazine decanoate for treatment of patients with schizophrenia. Neuropsychiatr Dis Treat (2011) 0.79
Possible association between DBH 19 bp insertion/deletion polymorphism and clinical symptoms in schizophrenia with tardive dyskinesia. J Neural Transm (Vienna) (2014) 0.77
Gender differences in the prevalence, risk and clinical correlates of tardive dyskinesia in Chinese schizophrenia. Psychopharmacology (Berl) (2009) 0.77
Tying comparative effectiveness information to decision-making and the future of comparative effectiveness research designs: the case for antipsychotic drugs. J Comp Eff Res (2012) 0.76
Metabolic syndrome and adverse clinical outcomes in patients with bipolar disorder. BMC Psychiatry (2016) 0.75
Enhanced 5-HT2C receptor signaling is associated with haloperidol-induced "early onset" vacuous chewing in rats: implications for antipsychotic drug therapy. Psychopharmacology (Berl) (2005) 0.75
Long-term efficacy and safety of iloperidone: results from 3 clinical trials for the treatment of schizophrenia. J Clin Psychopharmacol (2008) 1.04
Treatment strategies to prevent relapse and encourage remission. J Clin Psychiatry (2007) 0.97
Atypical antipsychotics: sedation versus efficacy. J Clin Psychiatry (2008) 0.88
An evidence-based strategy for remission in schizophrenia. J Clin Psychiatry (2008) 0.82